FDA regulations need more flexibility in time of emergencies, Domingo admits By ANNA FELICIA BAJO, GMA News
Published April 22, 2021 1:09pm Food and Drug Administration (FDA) director general Dr. Eric Domingo on Thursday admitted that the agency needs more flexibility in implementing its regulations especially in time of emergencies. At a House Committee on Good Government and Public Accountability hearing, Domingo stressed that the FDA would support proposed measures in Congress that will give them flexibility during emergencies. Kailangan talaga ng FDA ng mas flexibility lalo na kung panahon ng emergencies at support the local pharmaceutical industry, Domingo said. (The FDA needs flexibility especially in times of emergencies as well as support the local pharmaceutical industry.)
(Photo by SERGIO FLORES / GETTY IMAGES NORTH AMERICA / Getty Images via AFP / FILE PHOTO)
FDA director-general Eric Domingo told lawmakers in the House of Representatives that the agency is already exploring the possibilities to expand the list of its drug products under emergency use (DEU) amid the pandemic.
“Actually pinalawak na nga namin to living guidelines para mas maraming grupo na [ang] gumagawa…para pwede po nilang maisama doon sa living guidelines at maaral para ma-increase natin sa DEU (we have expanded our living guideline to include more groups…so they could include it and study the living guidelines to increase DEU),” Domingo said during the virtual hearing the House committee on good government and public public accountability.
endIndex:
Metro Manila (CNN Philippines, April 22) One more hospital has been given a compassionate special permit to use anti-parasitic drug ivermectin against COVID-19, Food and Drug Administration Director General Eric Domingo said Thursday, adding one more CSP application is pending with the agency.
The FDA issued the CSP to a hospital, which was not named, on Wednesday, Domingo announced during a hearing at the House of Representatives. Early this month, two other hospitals, also unnamed, got FDA s nod to prescribe this investigational drug to COVID-19 patients.
The FDA earlier said oral ivermectin products in the country are only approved for use on animals to prevent heartworm disease and treat infections caused by parasites. The agency added doctors can prescribe topical ivermectin products to individuals with parasitic infestations such as head lice and other skin conditions.
FDA asks Congress for law allowing more flexibility in regulations during emergencies mb.com.ph - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mb.com.ph Daily Mail and Mail on Sunday newspapers.
Another hospital, 3rd so far, given CSP to use ivermectin, FDA says By ANNA FELICIA BAJO, GMA News
Published April 22, 2021 2:09pm Food and Drug Administration (FDA) director general Eric Domingo on Thursday said a compassionate special permit (CSP) was given to another hospital for the use of anti-parasitic drug ivermectin as possible treatment for COVID-19. Sa ngayon po mayroon pa pong na-approve na isang hospital kahapon. May pending pa po na isa daw na nag-apply din kahapon na may kulang lang na papel na isa-submit, Domingo said at a congressional hearing, noting that three hospitals now have CSPs. (One hospital was given a compassionate special permit yesterday. There s still a pending application as the documents submitted were not yet complete.)